Page last updated: 2024-09-05

varenicline and Cognitive Dysfunction

varenicline has been researched along with Cognitive Dysfunction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Chen, Y; Hu, X; Huang, C; Li, A; Lu, W; Qian, C; Wang, J; Zhang, Y; Zhou, Y; Zhu, S1
Ebrahimi-Kalan, A; Farhoudi, M; Hosseini, L; Kazmi, S; Mahmoudi, J; Rahbarghazi, R; Sadigh-Eteghad, S; Seyedaghamiri, F; Shanehbandi, D1
Benson, C; Dark, F; De Monte, V; Gore-Jones, V; Kisely, S; Melo, CD; Rossell, SL; Shah, S; Siskind, D; Tanzer, T1
Golebiowska, J; Nikiforuk, A; Popik, P; Potasiewicz, A1
Kaakkola, S; Tuominen, R1
Barr, MS; Dermody, SS; George, TP; Kozak, K; Rabin, RA; Tyndale, RF; Zack, M1

Reviews

2 review(s) available for varenicline and Cognitive Dysfunction

ArticleYear
Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis.
    Psychopharmacology, 2020, Volume: 237, Issue:1

    Topics: Cognitive Dysfunction; Humans; Nicotinic Agonists; Schizophrenia; Varenicline

2020
[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
    Duodecim; laaketieteellinen aikakauskirja, 2013, Volume: 129, Issue:16

    Topics: Alzheimer Disease; Ataxia; Benzazepines; Cognitive Dysfunction; Epilepsy, Frontal Lobe; Humans; Mutation; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinoxalines; Receptors, Nicotinic; Tobacco Use Cessation Devices; Varenicline

2013

Trials

1 trial(s) available for varenicline and Cognitive Dysfunction

ArticleYear
Effects of varenicline on cognitive function in non-smokers with schizophrenia.
    Schizophrenia research, 2018, Volume: 197

    Topics: Adult; Cognitive Dysfunction; Double-Blind Method; Humans; Memory, Short-Term; Nicotinic Agonists; Non-Smokers; Schizophrenia; Space Perception; Treatment Outcome; Varenicline; Visual Perception

2018

Other Studies

3 other study(ies) available for varenicline and Cognitive Dysfunction

ArticleYear
Varenicline improved laparotomy-induced cognitive impairment by restoring mitophagy in aged mice.
    European journal of pharmacology, 2022, Feb-05, Volume: 916

    Topics: Aging; Animals; Apoptosis; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; eIF-2 Kinase; Laparotomy; Male; Maze Learning; Mice, Inbred C57BL; Mitochondria; Mitophagy; Neurons; Neuroprotective Agents; Oxidative Stress; Perioperative Care; Postoperative Cognitive Complications; STAT3 Transcription Factor; tau Proteins; Varenicline

2022
Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: The possible roles of inflammation, apoptosis, and synaptic factors.
    Brain research bulletin, 2022, Volume: 181

    Topics: Animals; Anxiety; Apoptosis; Behavior, Animal; Brain Ischemia; Cognitive Dysfunction; Disease Models, Animal; Mice; Neuroinflammatory Diseases; Nicotinic Agonists; Prefrontal Cortex; Synapses; Varenicline

2022
Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Journal of psychopharmacology (Oxford, England), 2018, 12-03, Volume: 33, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cognition; Cognitive Dysfunction; Disease Models, Animal; Drug Monitoring; Nicotinic Agonists; Rats; Receptors, Nicotinic; Schizophrenia; Treatment Outcome; Varenicline

2018